Last reviewed · How we verify
Placebo / Botulinum Toxin A — Competitive Intelligence Brief
marketed
Neurotoxin / Acetylcholine release inhibitor
SNAP-25 (synaptosome-associated protein of 25 kDa)
Neurology / Dermatology / Aesthetics
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo / Botulinum Toxin A (Placebo / Botulinum Toxin A) — Walter Reed Army Medical Center. Botulinum toxin A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo / Botulinum Toxin A TARGET | Placebo / Botulinum Toxin A | Walter Reed Army Medical Center | marketed | Neurotoxin / Acetylcholine release inhibitor | SNAP-25 (synaptosome-associated protein of 25 kDa) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Neurotoxin / Acetylcholine release inhibitor class)
- Walter Reed Army Medical Center · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo / Botulinum Toxin A CI watch — RSS
- Placebo / Botulinum Toxin A CI watch — Atom
- Placebo / Botulinum Toxin A CI watch — JSON
- Placebo / Botulinum Toxin A alone — RSS
- Whole Neurotoxin / Acetylcholine release inhibitor class — RSS
Cite this brief
Drug Landscape (2026). Placebo / Botulinum Toxin A — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-botulinum-toxin-a. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab